medical device company developing rapid-acting brain stimulation technology.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | VENN STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
— | |
| 2025 | VENN STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | VENN STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | VENN STRATEGIES |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | |
| 2024 | VENN STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
— | |
| 2024 | VENN STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | VENN STRATEGIES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | VENN STRATEGIES |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| VENN STRATEGIES | 8 | — |
| Issue | Activities |
|---|---|
| Health Issues | 8 |
| Budget/Appropriations | 1 |